LEGN
Closed
Legend Biotech corp
36.29
+0.80 (+2.25%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 35.49
Day's Range: 35.05 - 36.91
Send
sign up or login to leave a comment!
When Written:
51.27
Legend Biotech Corp is a clinical-stage biopharmaceutical company that focuses on developing and commercializing cell therapies for the treatment of cancer. The company is headquartered in Somerset, New Jersey, and was founded in 2015 as a spinoff from GenScript Biotech Corporation. Legend Biotech is a subsidiary of Genscript Biotech Corporation and is listed on the NASDAQ stock exchange under the ticker symbol "LEGN." The company's lead product candidate is LCAR-B38M, a chimeric antigen receptor T-cell therapy that targets B-cell maturation antigen for the treatment of multiple myeloma. Legend Biotech has partnerships with several leading pharmaceutical companies, including Janssen Biotech, Inc. and Takeda Pharmaceutical Company Limited, to develop and commercialize its cell therapy products.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








